(Q73082058)
Statements
Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients (English)
E T Zambidis
R K Barth
1 March 1997
scientific article published on 01 March 1997